Coronavirus May Boost Policy Efforts To Enhance US Drug, Medical Supply Production

Sen. Alexander says Congress should consider options to alleviate US dependence on other countries for drug and medical supply production once the outbreak subsides.

United States Capitol Building in Washington DC USA
FDA officials are determining whether API export restrictions imposed in India will affect the US drug supply. • Source: File photo

The US response to the coronavirus outbreak could serve as another vehicle for promoting an increase in domestic manufacturing of drugs and medical supplies as concerns about the effect on the supply chain grow.

Sen. Lamar Alexander, R-TN, and other members of the Senate Health, Education, Labor and Pensions Committee said that once the...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Manufacturing

More from Compliance